BioPhotas Receives FDA Clearance for the Celluma

BioPhotas has landed FDA clearance for its patented biophotonic medical device, the Celluma, indicated for treating facial wrinkles.

Previously, the low-level light therapy device was cleared for the following indications: the treatment of acne, muscle and joint pain, muscle and joint stiffness, muscle spasm, arthritis and compromised local blood circulation, the company says.

In a clinical study, participants saw a reduction in facial wrinkles 12 weeks after a four-week treatment period was completed.

The Celluma uses three wavelengths of light simultaneously to treat multiple skin, muscle and joint conditions. — Anisa Jibrell